BBT-176

· Bridge Biotherapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BBT-176, covering 2025-06-06 to 2025-06-06. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1/2 Study of BBT-176 in Advanced NSCLC With Progression After EGFR TKI Treatment [Phase 1, Phase 2]